Published: 14 February 2022  (Updated: 14 February 2022)

CTPA Public Statement on the Legal Status of BMHCA/Lilial in GB

Following many requests for advice from both members and non-members of CTPA, as well as sister associations, retailers and other stakeholders, CTPA is issuing this public statement to clarify the legal status of butylphenyl methylpropional (BMHCA), sometimes known by its trade name ‘Lilial’, in the market of Great Britain.  The statement clarifies that the legal status of BMHCA/lilial in GB is different from that of the EU/NI, as different legislations are applicable in the two markets.  CTPA expects a ban on BMHCA/lilial to come into force in GB in the near future.

Companies and stakeholders can keep track of ingredients divergence between the EU and GB in this public resource of the CTPA website.

Find us on...